Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2592635 | 0.80 | ALDH1A1 (0.35) | — | |
| Boric Acid SCHEMBL3714295 | 0.79 | ORAI1 (0.36) | ESR1ESR2 | |
| SCHEMBL27562234 | 0.76 | — | — | |
| Thiourea SCHEMBL6835360 | 0.73 | TSHR (0.38) | — | |
| SCHEMBL4451075 | 0.73 | AR (0.46) | ESR1ESR2 | |
| SCHEMBL5716618 | 0.71 | CTSL (0.44) | ESR1ESR2 | |
| SCHEMBL4958933 | 0.69 | ORAI1 (0.47) | — | |
| SCHEMBL8020031 | 0.69 | CTSS (0.38) | — | |
| SCHEMBL5892467 | 0.67 | ESR1 (0.52) | ESR1ESR2 | |
| SCHEMBL18069659 | 0.67 | POLB (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112513051-B | Compound and color conversion film comprising the same | 株式会社LG化学 | 2023-12-26 | — | — | CN | disclosed |
| EP-4279565-A2 | THIOPHENE COMPOUND, LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME | Merck Patent GmbH (DE) | 2023-11-22 | — | — | EP | disclosed |
| CN-109554181-B | Liquid crystal medium and liquid crystal display comprising same | 默克专利股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| EP-3763802-B1 | THIOPHENE COMPOUND, LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME | MERCK PATENT GMBH (DE) | 2023-09-06 | — | — | EP | disclosed |
| CN-109207161-B | Liquid crystal medium and liquid crystal display comprising same | 默克专利股份有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-110023457-B | Liquid crystal medium and liquid crystal display comprising same | 默克专利股份有限公司 | 2023-08-18 | — | — | CN | disclosed |
| EP-4126878-A1 | COMPOUNDS AS CASEIN KINASE INHIBITORS | Gritscience Biopharmaceuticals Co., Ltd. (CN) | 2023-02-08 | — | — | EP | disclosed |
| CN-111148734-B | Pyrrole-2-formamide compound and preparation method and application thereof | 中国医学科学院药物研究所 | 2023-01-06 | — | — | CN | disclosed |
| US-11168255-B2 | Thiophene compound, liquid-crystalline medium and liquid-crystal display comprising the same | MERCK PATENT GMBH (DE) | 2021-11-09 | — | — | US | disclosed |
| US-11060029-B2 | Liquid-crystalline medium and liquid-crystal display comprising the same | MERCK PATENT GMBH (DE) | 2021-07-13 | — | — | US | disclosed |
| US-20060177694-A1 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2006-08-10 | — | — | US | disclosed |
| CN-1474826-A | Light emitting device and display | ������������ʽ���� | 2004-02-11 | — | — | CN | disclosed |
| EP-1348711-A1 | LUMINESCENT ELEMENT AND DISPLAY | CANON KABUSHIKI KAISHA (JP) | 2003-10-01 | — | — | EP | disclosed |
| US-20030068526-A1 | Such as tetrakis(1-(5-heptyloxyphenyl)isoquinoline-C2,N) (pu-dichloro) iridium (III); for red luminescence; graphic arts | CANON KABUSHIKI KAISHA (JP) | 2003-04-10 | — | — | US | disclosed |
| EP-1246797-A1 | CYCLOPENTYL SULFONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2002-10-09 | — | — | EP | disclosed |
| EP-1189905-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES | Bristol-Myers Squibb Pharma Company (US) | 2002-03-27 | — | — | EP | disclosed |
| WO-2001042203-A1 | CYCLOPENTYL SULFONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2001-06-14 | — | — | WO | disclosed |
| WO-2000077001-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-12-21 | — | — | WO | disclosed |
| EP-0968158-A1 | METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM | Basell Polyolefine GmbH (DE) | 2000-01-05 | — | — | EP | disclosed |
| WO-1998040331-A1 | PREPARATION OF PREPARING SUBSTITUTED INDANONES | TARGOR GMBH (DE) | 1998-09-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060177694-A1 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | AP3M1, MLEC, MLX | ESR1 3111/4885ESR2 2096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.